MarketsandMarkets is delighted to announce the 2nd Annual Plant Based and Alternative Protein Conference, scheduled for 23rd - 24th October 2023 in Chicago, USA. This conference will gather industry leaders, researchers, innovators, and professionals from the plant-based and alternative protein sectors to explore the latest trends, developments, and opportunities in the rapidly growing market.

Conference Registration: https://events.marketsandmarkets.com/plant-based-and-alternative-protein-conference/register

The 2nd Annual Plant-Based and Alternative Protein Conference will provide a platform for attendees to gain insights into the future of food by focusing on plant-based and alternative protein solutions. The conference will cover a wide range of topics, including market trends, consumer preferences, sustainable production methods, product innovations, regulatory challenges, and investment opportunities.

https://events.marketsandmarkets.com/plant-based-and-alternative-protein-conference/register

https://events.marketsandmarkets.com/plant-based-and-alternative-protein-conference/register

Process R&D is vital in the development of pharmaceuticals and therapies yet more and more companies are being put under pressure to reduce time, costs and risk associated with process R&D to make treatments widely available and accessible to patients. In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D.Pharmaceutical process research and development (R&D) is indispensable in the development of personalised medicines and innovative treatments that deal effectively with diseases. In order to make treatments widely available and accessible to patients, the pressure to demonstrate improved outcomes at lower costs is getting higher. This is particularly true when Europe faces increasing competition from emerging economies, such as Brazil and China.1

This is where contract research and development organisations (CDMOs) can play a critical role in helping drug makers develop competitive processes without patent infringement risks and short time-to-market. But first things first…

Read more: https://www.epmmagazine.com/opinion/under-pressure-how-to-get-the-best-out-of-process-r-d/

If you have any challenges for the Analytical R&D Specialist, please let me know!

Research & Development business target high skill market in North aArica  

I have a PhD in Biomedical Sciences on prions and then transitioned to the infectious diseases and diagnostic domain. I am a Health improvement driven life sciences specialist with over 10 years in project management (academic, hospital, INGO). I conducted a wide range of projects (scientific, medical, infrastructure, laboratory, public health, QA) due to my curiosity/adaptability and willingness to learn and develop my skills. Problem solver who keeps looking for improvement and optimization. I completed my projects in due time and in the respect of the budgets. Open-minded manager who looks at working with his team ensuring proficiency and efficacy to achieve organizational objectives.

I have spent almost 4 years in a low income country in south east asia as country manager and scientific project manager for an INGO. I am now looking to relocate to France (ideally Paris and the surroundings) and to switch to the Biotech / Pharma sector.

I am looking for a thrilling new job where I can learn and develop new skills and share and used the knowledge and skills I already own. If you want to know more about me don't hesitate to contact me. Any leads would be really appreciated.
Best regards

Laurent

Hello! I am a recent PhD graduate in Biomedicine with a focus on Stem Cell Biology from Lund University, Sweden. My research work revolved around neural stem cells and the role of their regulators in brain tumor development. I have a purely academic background in stem cell biology and molecular biology and I am trying to transition to industry. I am also a copyeditor. I am looking for entry level opportunities in Life Science, more specifically in Regulatory Affairs, Quality Control, Project Management, Process Management, or as a Medical/Scientific Writer or Technical Coordinator. I would be willing to relocate. After so many years in academia, I want to at last contribute tangibly to healthcare and be part of something bigger and more meaningful. Any leads would be highly appreciated! Best regards, Isabelle.

 



Head
of Discovery



Reports to the Senior VP Research Innovation &
Business Development and manages 45
people. Based in France, North of Paris.

Stakes:

§  Scientific and
technical challenges:

-     Define medical
needs and identify new research axis and programs

-     Define, propose
and implement the Discovery strategy

-     Implement,
drive and manage an Openlab approach. 

§  Managerial challenges:

-     Propose,
implement and manage an optimal organisation

-     Create a design
lab to test the suggestions from Business Development

-     Develop and
drive external international partnerships and develop the Open Innovation.

Position
Assets:

Ø The medical
imaging market:

-     In full
expansion: Driven by the evolution of computing and the orientation of medicine
towards preventive medicine and personalised medicine

-     In steady
growth, driven by global population growth, better access to care in emerging
countries, aging population and development of chronic diseases

-     The development
of Interventional and minimally invasive therapy guided by imaging.

Ø The company:

-     Pioneer in the
field of contrast products with over 90 years of experience

-     Among the Top 3
in worldwide medical imaging

-     Complete range
of contrast products for X-ray, MRI, IRT & Injectors

-     Sustained
investments in R&D

-     Strong dynamics
and great growth potential

-     Direct presence
on the main markets (USA, Japan, Europe and South Korea)

-     An actor in
Public Health: improve the diagnosis and the therapeutic management of
patients.

Ø The position:

-     Very
comprehensive position: strategy, operations, management, external partnerships
and open innovation

-     Lead and boost
the dynamics of innovation

-     Global position
within the global Research & Innovation

-     Be an actor in
the group’s new history in Interventional medical device

-     Visible
position, enabling recognition and appreciation

-     Position with
prospects for development within the Group.

Profile:

§  Degree: PhD
level, fairly generalist in order to understand the In-Vivo:

-     in Organic
Chemistry, Biomaterials, Polymers, Biology, Oncology...

-     or equivalent,
Medical Doctor, DVM, Pharmacist.

§  Experience: Minimum 10 years in medical research, first-line
in a medical device manufacturer in interventional radiology / minimally
invasive therapy guided by imagery / or in pharmaceutical industry, in
oncology, vascular or neurology.

§  Required
Skills:

-     Management of
research managers (PhD)

-     Driving the
Discovery action plan with monitoring indicators

-     Evaluation,
selection, development and management of public and private partnerships 

-     English and
French: Fluent written and oral.

§  Favourable skills:


Experience in:
Early development / medical implants (classes 2b/3) / Open innovation.

 

Contact à Dr Véronique
DUGUÉ, GIUDICELLI INTERNATIONAL Executive Search:

vdugue@giudicelli-international.com

Hi EVERYONE, I am currently working as a postdoc researcher in the university of padova in the clinical oncology department. I am looking for opportunities in the R&D or Quality control department in the pharma/biotech industry in Europe as I have previous experiences in these fields. Thanks in advance.

Forming a stable dispersion of the local anesthetic n‐butyl‐p aminobenzoate ( Butamben) for epidural administration.

 

The purpose of this study is to form a uniform, stable suspension
of n‐butyl‐p‐aminobenzoate which can be used
for epidural administration. All additives used should be approved
for injection in the human body. When precipitated, the particles should be
able to give a homogenous suspension after shaking. Particles produced with
three methods will be compared based on size, release, shape and injectability
through the catheter. The methods used are a microfluidic system.

To produce uniform and stable microparticles a new developed technology
from EmulTech Eindhoven can be used. In this technology, different micro-channels
cross each other, forming the micro‐particles in the outgoing channel.

My question is (What is the best stabilizer that I can used in this
suspense?) Knowing that the size of the particles
must be (1-10) micrometer.

Any ideas??????